BOSTON, April 1, 2024 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has completed its previously announced acquisition of privately-held Chicago-based Attune Medical, the manufacturer of the ensoETM® proactive esophageal cooling device. EnsoETM is the only FDA-cleared temperature regulation device indicated for esophageal protection […]
Tag: Attune Medical
Attune Medical and Heart Rhythm Clinical Research Solutions (HRCRS) Collaborate with Real World Evidence Consortium Members to Evaluate ensoETM™ in High Volume Centers
Real world study will investigate throughput and patient experiences with proactive esophageal cooling. CHICAGO–(BUSINESS WIRE)–Attune Medical and Heart Rhythm Clinical Research Solutions (HRCRS) are partnering on an evaluation of Attune’s ensoETM thermal regulating device through the HRCRS Real World Evidence (RWE) consortium. HRCRS will conduct a multi-center observational study through the RWE network of […]
FDA Grants IDE Approval to Evaluate Attune Medical’s ensoETM in Radiofrequency Ablation Procedures
US Arm of IMPACT II Study Will Ascertain Reduction of Esophageal Thermal Injury During Cardiac RF Ablation Procedures CHICAGO–(BUSINESS WIRE)–The US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to Attune Medical to evaluate the company’s ensoETM in the reduction of esophageal thermal injury during cardiac radiofrequency ablation […]
First Patients Enrolled in IMPACT II Study to Evaluate Attune Medical’s ensoETM for Radiofrequency Ablation Procedures
Continued Research into Efficacy of ensoETM for RF Ablation Procedures Will Support Future Regulatory Efforts for Expanded Indications CHICAGO–(BUSINESS WIRE)–Attune Medical, a pioneering medical device company with a technology platform based on temperature management using the esophagus, announced today that the first patients have been enrolled in the Improving Oesophageal Protection During […]
Late-Breaking Clinical Study Presented at AF Symposium 2020 Evaluates Attune Medical’s ensoETM For Use During Cardiac Ablation Procedures
CHICAGO–(BUSINESS WIRE)–Chicago-based medical device firm Attune Medical announced the presentation of clinical results from the largest device study to date designed to evaluate the performance of its ensoETM patient temperature management device as an aid in the reduction of esophageal injury during cardiac ablation, a common treatment for atrial fibrillation. […]
Attune Medical Expands IP Portfolio with Issuance of Additional Patent from USPTO and Acquisition of License from Stanford University
CHICAGO–(BUSINESS WIRE)–Chicago-based medical device firm Attune Medical has expanded its pioneering patent portfolio with two major advancements. The USPTO recently issued a broad method patent for Devices and Methods for Controlling Patient Temperature (US Patent number 10,363,162), which is the first patent in the Attune portfolio that specifically claims the […]
